Cytek Biosciences reports preliminary Q4 revenue of $62 million
Go back to Cytek Biosciences reports preliminary Q4 revenue of $62 million| (NASDAQ: CTKB) | Delayed: 4.60 -0.02 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.62 | 52 Week High | $ | |||
| Open | $4.66 | 52 Week Low | $ | |||
| Day High | $4.78 | P/E | N/A | |||
| Day Low | $4.58 | EPS | $ | |||
| Volume | 180,452 | |||||

